Prostate tumor progression and prognosis. interplay of tumor and host factors (Q30306149)

16 June 2017

title

Prostate tumor progression and prognosis. interplay of tumor and host factors (English)

1 reference

16 June 2017

1 reference

1 reference

Harding MA

1

1 reference

16 June 2017

Theodorescu D

series ordinal

2

1 reference

16 June 2017

language of work or name

1 reference

1 November 2000

1 reference

16 June 2017

1 reference

16 June 2017

volume

5

1 reference

16 June 2017

issue

6

1 reference

16 June 2017

page(s)

258-264

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

16 June 2017

1 reference

7 January 2021

Critical determinants of cancer metastasis: rationale for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Prognostic markers in localized prostate cancer: from microscopes to molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Diagnostic and prognostic markers for human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Neuroendocrine differentiation in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Tumor dormancy in vivo by prevention of neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Tumor induction of VEGF promoter activity in stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Quantitative angiogenesis assays: progress and problems

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Fractal characteristics of tumor vascular architecture during tumor growth and regression

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Targeting gene expression to hypoxic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Clinical relevance of the individual prostate cancer focus

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Aneuploidy index in blood: a potential marker for early onset, androgen response, and metastasis in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Identification of bone marrow micrometastases in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2800%2900073-9

7 January 2021

10.1016/S1078-1439(00)00073-9

Identifiers

DOI

1 reference

16 June 2017

1 reference